ICON Public Limited Company
NASDAQ:ICLRMedical - Diagnostics & Research
-$0.27 today
- Market cap
- $14.62B
- Beta
- 1.27
- P/E (TTM)
- 23.0
- EPS (TTM)
- $6.23
Volume 0.55M
Average 1.15M
ICLR Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
ICON Public Limited CompanyNASDAQ: ICLR
Accounts Receivables · Q2 FY2026 · quarter ended Jun 2026
Accounts receivables declines year over year
Q2 FY2026 accounts receivables of $15.29M (cash outflow) fell 54.3% year over year, ahead of the -194.6% change in trailing-twelve-month accounts receivables. Over 3 fiscal years it compounded at -39.2% a year.
Context
- Accounts receivables amounted to 2.1% of revenue in FY2025, up 1.9 pp from a year earlier.
- Accounts receivables increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of -54.3% holds above the trailing-twelve-month pace of -194.6%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- (169.32M) USD
- Year-over-year change
- -1903.6%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (169.32M) | -1903.6% |
| FY2024 | 2024-12-31 | 9.39M | +111.9% |
| FY2023 | 2023-12-31 | (78.58M) | +89.6% |
| FY2022 | 2022-12-31 | (753.29M) | -885.8% |
| FY2021 | 2021-12-31 | 95.86M | — |
Accounts Receivables vs competitors
How ICLR compares with its peers on the latest reported figures
- ICLR's LTM Jun 2026 accounts receivables of $149.65M is the 2nd largest of the 6 companies compared; the peer median is $32.91M.
- Its year-over-year change of -194.6% is the 4th highest of 6, against a peer median of -88.6%.
- Accounts receivables amounts to 1.8% of revenue for ICLR, versus a peer median of 1.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $240.4M | -2961.9% | — | 1.7% | |
| LTM Jun 2026 | $149.65M | -194.6% | -39.2% | 1.8% | |
FTREFortrea Holdings Inc. | LTM Jun 2026 | $78.4M | +168.5% | — | 2.9% |
| LTM Sep 2026 | $74.24M | +20.0% | +16.6% | 2.6% | |
| LTM Jun 2026 | $32.91M | -1705.3% | — | 0.8% | |
| LTM Jun 2026 | $30M | -88.6% | — | 0.2% | |
| Peer median (excluding ICLR) | $32.91M | -88.6% | +16.6% | 1.7% | |
Competitors are the stored peer set for ICLR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 153.19M | 505.3M | 612.34M | 791.47M | 229.34M |
| Depreciation & Amortization | 314.99M | 569.51M | 585.95M | 488.5M | 383M |
| Deferred Income Tax | (60.62M) | (124.99M) | (85.4M) | 0 | (128.92M) |
| Stock-Based Compensation | 133.84M | 70.52M | 55.67M | 45.87M | 102.04M |
| Change in Working Capital | 135M | (550.22M) | (114.82M) | (56.51M) | (98.1M) |
| Accounts Receivables | 95.86M | (753.29M) | (78.58M) | 9.39M | (169.32M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | 39.14M | 203.07M | (36.24M) | (65.9M) | 71.22M |
| Other Non-Cash Items | 152.75M | 93.18M | 107.3M | 17.32M | 548.85M |
| Operating Cash Flow | 829.14M | 563.32M | 1.16B | 1.29B | 1.04B |
| Capital Expenditures | (93.75M) | (142.16M) | (140.69M) | (168.06M) | (174.21M) |
| Acquisitions (Net) | (5.92B) | (1.91M) | (71.77M) | (84.16M) | (2.54M) |
| Purchases of Investments | (4.06M) | (6.09M) | (16.81M) | (17.26M) | (19.87M) |
| Sales of Investments | 497K | 2.39M | 2.62M | 2.69M | 9.09M |
| Other Investing Activities | (10M) | 1.91M | 0 | 0 | 0 |
| Investing Cash Flow | (6.02B) | (145.87M) | (226.65M) | (266.79M) | (187.53M) |
| Debt Repayment | 5.03B | (800M) | (895M) | (360.28M) | (29.76M) |
| Common Stock Issued | 117.74M | 35.84M | 50.97M | 36.19M | 9.72M |
| Common Stock Repurchased | 0 | (99.98M) | 0 | (500M) | (750M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (30.33M) | (34K) | (16K) | (13.09M) | (1.22M) |
| Financing Cash Flow | 5.11B | (864.17M) | (844.04M) | (837.18M) | (771.26M) |
| Effect of Forex Changes | (7.73M) | (16.72M) | (997K) | (22M) | 31.1M |
| Net Change in Cash | (88.09M) | (463.45M) | 89.33M | 160.68M | 108.51M |
| Free Cash Flow | 735.39M | 421.16M | 1.02B | 1.12B | 861.99M |
ICON Public Limited Company
NASDAQ:ICLR
Intrinsic Alpha fair value
Locked
Current Price
$195.16
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.